Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...

Researchers found that TYK2 plays a crucial role in the abnormal transformation of the tau protein, a key factor in the ...

Scientists have discovered that the enzyme TYK2 modifies tau proteins, leading to their accumulation in the brain—a key ...

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital and collaborating institutions discovered that the enzyme ...

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s disease drug candidate on the cusp of the release of phase 2a data.

Researchers at Tel Aviv University and the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center have demonstrated that hyperbaric oxygen therapy (HBOT) improves the ...

Roche already has one Alzheimer’s candidate in its pipeline targeting tau, but has added a second via a deal with Belgian drugmaker UCB worth up to $2 billion. The Swiss pharma group is paying $ ...

Veravas Partners with Phanes Biotech to Co-develop a Next-generation Blood-based Tau Pathology Test to Improve Alzheimer's Disease Detection First-in-class blood-based assay is designed to ...

A common drug used to treat glaucoma has shown promise for neurodegenerative disease. The drug was able to prevent the buildup of an abnormal protein called tau – implicated in dementia and more ...

Glia then sail in to mop up the spill, containing the oils within intracellular droplets for use later on as fuel. Tau plays an essential role in the production of these droplets, according to a paper ...